SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:uu ;srt2:(2005-2009);pers:(Isaksson Anders)"

Sökning: LAR1:uu > (2005-2009) > Isaksson Anders

  • Resultat 11-20 av 26
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Hassan, Saadia, et al. (författare)
  • Gene expression signature-based chemcial genomics and activity pattern in a panel of tumour cell lines propose linalyl acetate as a protein kinase/NF-κB inhibitor
  • 2008
  • Ingår i: Gene Therapy and Molecular Biology. - 1529-9120. ; 12:B, s. 359-370
  • Tidskriftsartikel (refereegranskat)abstract
    • The essential oil of Lebanese sage, Salvia libanotica, was reported to have anti-tumour activity; however, the mechanism of action has not been identified yet. In this study, 14- cancer cell lines including drug-sensitive and resistant lung, leukaemia, and colon, as well as primary human tumours of chronic lymphocytic leukaemia (CLL) and primary normal mononuclear cells (PBMCs) were used to characterize the anti-tumour activity and mechanism of action of linalyl acetate, a component of the Lebanese sage essential oil. Drug activity and gene expression data sets were utilized to identify drugs with similar activity patterns and genes involved in drug sensitivity/resistance. In addition, the Connectivity Map, a gene expression signature-based screening approach, assisted in predicting further the molecular action of linalyl acetate. Small cell lung carcinoma and colorectal cancer cell lines were the most sensitive to the drug and greater tumour selectivity was observed against chronic lymphocytic leukaemia cells compared to normal mononuclear cells. Only limited effect of some of the classical mechanisms of multi-drug resistance on the activity of Linalyl acetate was noted which makes it potentially interesting for drug-resistant patients. There was high similarity between the activity-pattern/gene expression profile of linalyl acetate and that of protein kinase/NF-kappa B inhibitors. Validating this, linalyl acetate was found to strongly inhibit Janus kinase, JAK3, and p38 alpha kinases in a cell-free assay as well as the NF-kappa B translocation in a dose-dependent manner. Taken together, our results show that the NF-kappa B inhibitor, linalyl acetate, may represent a new therapeutic compound in the management of inflammation and cancer.
  •  
12.
  • Hägerstrand, Daniel, et al. (författare)
  • Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
  • 2006
  • Ingår i: Oncogene. - : Springer Science and Business Media LLC. - 0950-9232 .- 1476-5594. ; 25:35, s. 4913-4922
  • Tidskriftsartikel (refereegranskat)abstract
    • High-grade gliomas, including glioblastomas, are malignant brain tumors for which improved treatment is urgently needed. Genetic studies have demonstrated the existence of biologically distinct subsets. Preliminary studies have indicated that platelet-derived growth factor (PDGF) receptor signaling contributes to the growth of some of these tumors. In this study, human high-grade glioma primary cultures were analysed for sensitivity to treatment with the PDGF receptor inhibitor imatinib/Glivec/Gleevec/STI571. Six out of 15 cultures displayed more than 40% growth inhibition after imatinib treatment, whereas seven cultures showed less than 20% growth inhibition. In the sensitive cultures, apoptosis contributed to growth inhibition. Platelet-derived growth factor receptor status correlated with imatinib sensitivity. Supervised analyses of gene expression profiles and real-time PCR analyses identified expression of the chemokine CXCL12/SDF-1 (stromal cell-derived factor 1) as a predictor of imatinib sensitivity. Exogenous addition of CXCL12 to imatinib-insensitive cultures conferred some imatinib sensitivity. Finally, coregulation of CXCL12 and PDGF alpha-receptor was observed in glioblastoma biopsies. We have thus defined the characteristics of a novel imatinib-sensitive subset of glioma cultures, and provided evidence for a functional relationship between imatinib sensitivity and chemokine signaling. These findings will assist in the design and evaluation of clinical trials exploring therapeutic effects of imatinib on malignant brain tumors.
  •  
13.
  • Isaksson, Anders, et al. (författare)
  • Cross-validation and bootstrapping are unreliable in small sample classification
  • 2008
  • Ingår i: Pattern Recognition Letters. - : Elsevier BV. - 0167-8655 .- 1872-7344. ; 29:14, s. 1960-1965
  • Tidskriftsartikel (refereegranskat)abstract
    • The interest in statistical classification for critical applications such as diagnoses of patient samples based on supervised learning is rapidly growing. To gain acceptance in applications where the subsequent decisions have serious consequences, e.g. choice of cancer therapy, any such decision support system must come with a reliable performance estimate. Tailored for small sample problems, cross-validation (CV) and bootstrapping (BTS) have been the most commonly used methods to determine such estimates in virtually all branches of science for the last 20 years. Here, we address the often overlooked fact that the uncertainty in a point estimate obtained with CV and BTS is unknown and quite large for small sample classification problems encountered in biomedical applications and elsewhere. To avoid this fundamental problem of employing CV and BTS, until improved alternatives have been established, we suggest that the final classification performance always should be reported in the form of a Bayesian confidence interval obtained from a simple holdout test or using some other method that yields conservative measures of the uncertainty.
  •  
14.
  • Laryea, Daniel, et al. (författare)
  • Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients
  • 2009
  • Ingår i: Investigational new drugs. - : Springer Science and Business Media LLC. - 0167-6997 .- 1573-0646. ; 27:5, s. 402-411
  • Tidskriftsartikel (refereegranskat)abstract
    • The plant derived indoloquinoline alkaloid cryptolepine was investigated for its cytotoxic properties in 12 human tumour cell lines and in primary cultures of tumour cells from patients. The fluorometric microculture cytotoxicity assay was used to assess cytotoxicity and DNA micro-array analysis to evaluate gene expression. Cryptolepine mean IC(50) in the cell line panel was 0.9 muM compared with 1.0 and 2.8 muM in haematological and solid tumour malignancies, respectively. Among patient solid tumour samples, those from breast cancer were the most sensitive and essentially as sensitive as haematological malignancies. Cryptolepine activity showed highest correlations to topoisomerase II and microtubule targeting drugs. In the cell lines cryptolepine activity was essentially unaffected by established mechanisms of drug resistance. A number of genes were identified as associated with cryptolepine activity. In conclusion, cryptolepine shows interesting in vitro cytotoxic properties and its further evaluation as an anti-cancer drug seems warranted.
  •  
15.
  •  
16.
  • Melin, Malin, et al. (författare)
  • Constitutional downregulation of SEMA5A expression in autism.
  • 2006
  • Ingår i: Neuropsychobiology. - : S. Karger AG. - 0302-282X .- 1423-0224. ; 54:1, s. 64-9
  • Tidskriftsartikel (refereegranskat)abstract
    • There is strong evidence for the importance of genetic factors in idiopathic autism. The results from independent twin and family studies suggest that the disorder is caused by the action of several genes, possibly acting epistatically. We have used cDNA microarray technology for the identification of constitutional changes in the gene expression profile associated with idiopathic autism. Samples were obtained and analyzed from 6 affected subjects belonging to multiplex autism families and from 6 healthy controls. We assessed the expression levels for approximately 7,700 genes by cDNA microarrays using mRNA derived from Epstein-Barr virus-transformed B lymphocytes. The microarray data were analyzed in order to identify up- or downregulation of specific genes. A common pattern with nine downregulated genes was identified among samples derived from individuals with autism when compared to controls. Four of these nine genes encode proteins involved in biological processes associated with brain function or the immune system, and are consequently considered as candidates for genes associated with autism. Quantitative real-time PCR confirms the downregulation of the gene encoding SEMA5A, a protein involved in axonal guidance. Epstein-Barr virus should be considered as a possible source for altered expression, but our consistent results make us suggest SEMA5A as a candidate gene in the etiology of idiopathic autism.
  •  
17.
  • Melin, Malin, 1977- (författare)
  • Identification of Candidate Genes in Four Human Disorders
  • 2006
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • The aim of this thesis has been to identify genes and gene regions underlying four different disorders. In papers I-IV, positional cloning methods, such as linkage, association and haplotype analysis have been used for the identification of genomic regions associated with the ichthyosis prematurity syndrome (IPS), adult-onset autosomal dominant leukodystrophy (ADLD) and Kostmann disease. IPS is a rare autosomal recessive skin disorder, which includes a premature birth of the affected child. We mapped the IPS locus to a region on chromosome 9q34, and within this region a haplotype is shared by IPS patients, which suggests a strong founder effect. The haplotype spans 76 kb, which includes four known genes. No sequence or mRNA expression alterations could be detected for the four genes in IPS patients. A candidate region for an adult-onset leukodystrophy (ADLD) on chromosome 5 was investigated in a large Swedish family with ADLD. A significant multipoint LOD score of 9.45 was obtained for markers in the chromosome 5 region and fine-mapping of recombination events restricts a candidate gene region to 1.5 Mb. Kostmann disease is an autosomal recessive form of severe congenital neutropenia. We have identified a 1.2 Mb region on chromosome 1q22 associated with the disease in the original Kostmann family. The region contains 37 genes. In paper V, cDNA microarrays were used to asses the mRNA levels of 7,700 genes in lymphoblastoid cell lines derived from autistic and control samples. The SEMA5A gene, which is involved in axonal guidance, was found downregulated in the cells derived from autistic individuals, and this was confirmed by quantitative PCR. In summary, candidate genes or gene regions have been identified for all four disorders and further studies are needed to confirm their roles in the pathogenesis of the disorders.
  •  
18.
  • Milani, Lili, et al. (författare)
  • Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells
  • 2007
  • Ingår i: Nucleic Acids Research. - : Oxford University Press (OUP). - 0305-1048 .- 1362-4962. ; 35:5, s. E34-
  • Tidskriftsartikel (refereegranskat)abstract
    • Using the relative expression levels of two SNIP alleles of a gene in the same sample is an effective approach for identifying cis-acting regulatory SNPs (rSNPs). In the current study, we established a process for systematic screening for cis-acting rSNPs using experimental detection of Al as an initial approach. We selected 160 expressed candidate genes that are involved in cancer and anticancer drug resistance for analysis of All in a panel of cell lines that represent different types of cancers and have been well characterized for their response patterns against anticancer drugs. Of these genes, 60 contained heterozygous SNPs in their coding regions, and 41 of the genes displayed imbalanced expression of the two cSNP alleles. Genes that displayed Al were subjected to bioinformatics-assisted identification of rSNPs that alter the strength of transcription factor binding. rSNPs in 15 genes were subjected to electrophoretic mobility shift assay, and in eight of these genes (APC, BCL2, CCND2, MLH1, PARP1, SLIT2, YES1, XRCC1) we identified differential protein binding from a nuclear extract between the SNIP alleles. The screening process allowed us to zoom in from 160 candidate genes to eight genes that may contain functional rSNPs in their promoter regions.
  •  
19.
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 26
Typ av publikation
tidskriftsartikel (24)
doktorsavhandling (2)
Typ av innehåll
refereegranskat (24)
övrigt vetenskapligt/konstnärligt (2)
Författare/redaktör
Göransson, Hanna (10)
Larsson, Rolf (10)
Fryknäs, Mårten (10)
Gustafsson, Mats G. (10)
Nygren, Peter (7)
visa fler...
Rosenquist, Richard (3)
Pettersson, Ulf (3)
Gustafsson, Mats (2)
Syvänen, Ann-Christi ... (2)
Juliusson, Gunnar (2)
Borg, Åke (2)
Staaf, Johan (2)
Dahl, Niklas (2)
Pontén, Fredrik (1)
Holmberg, Lars (1)
Carlsson, B (1)
Wallin, Göran (1)
Landegren, Ulf (1)
Bergqvist, Michael (1)
Pejler, Gunnar (1)
Lambe, Mats (1)
Heldin, Nils-Erik (1)
Hammerling, Ulf (1)
Hassan, Saadia (1)
Råstam, Maria, 1948 (1)
Öberg, Fredrik (1)
Jurlander, Jesper (1)
Strömberg, Sara (1)
Ekman, Simon (1)
Grimelius, Lars (1)
Gillberg, Christophe ... (1)
Stridsberg, Mats (1)
Hesselager, Göran (1)
Höglund, Mattias (1)
Lindgren, David (1)
Ringnér, Markus (1)
Vallon-Christersson, ... (1)
Bengtsson, Mats (1)
Larsson, Catharina (1)
Hjalgrim, Henrik (1)
Anckarsäter, Henrik, ... (1)
Simonsson, Bengt (1)
Soeria-Atmadja, Dani ... (1)
Lindstedt, Göran (1)
Lindhagen, Elin (1)
Micke, Patrick (1)
Östman, Arne (1)
Liljedahl, Ulrika (1)
Becker, Charlotte (1)
visa färre...
Lärosäte
Uppsala universitet (26)
Karolinska Institutet (4)
Lunds universitet (2)
Göteborgs universitet (1)
Kungliga Tekniska Högskolan (1)
Sveriges Lantbruksuniversitet (1)
Språk
Engelska (23)
Odefinierat språk (2)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Teknik (3)
Medicin och hälsovetenskap (3)
Naturvetenskap (2)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy